BioSpace News Archive

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Stephen Hoge, President, will participate in the Chardan Virtual 4th Annual Genetic Medicines Conference on October 5, 2020 at 2:00 p.m. ET.

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced the OH0120 and OH0130 ASIC-based boards—the newest members of its award-winning OVMed® medical image signal processor (ISP) family, designed to pair with its high performance medical image sensors for quick integration into single-use and reusable endoscopes as well as catheters.

Therapeutics Solutions International, Inc., (OTC Markets: TSOI), reported today positive preclinical data demonstrating superior neuro-regenerative activity to other cell therapies such as mesenchymal stem cells.

Paragonix Technologies announced that its Paragonix SherpaPak™ Cardiac Transport System (CTS) for donor heart preservation and transport is now being used by Stanford Health Care, the first heart transplant center on the West Coast of the United States to implement the system as standard of care for its heart transplant program.

XtalPi, an Artificial Intelligence (AI) drug discovery and development technology company, today announces an oversubscribed Series C funding of $318.8 million co-led by SoftBank Vision Fund 2i, PICC Capital, and Morningside.

Partnerships are on Diaceutics’ DXRX platform – the world’s first diagnostic network for precision medicine Platform, launching in Q4 2020, has been purpose built to enable collaboration between key stakeholders in precision medicine to solve real-world biomarker testing issues Pharmaceutical companies will gain greater oversight of diagnostic testing standards for their new and planned precision medicines Will enable individu

OneClick.chat, an innovative video chat platform, today announced positive outcomes in the study of older adults, with and without mild cognitive impairment (MCI), who used their video chat technology to engage in social activities to meet new people of all ages with shared interests.

Bayer announced today that the European Commission has authorized XtendFlex soybean technology for food, feed, import and processing in the European Union. This milestone represents the final key authorization for XtendFlex soybeans. With this approval in hand, Bayer can now look forward to a full launch in the United States and Canada in 2021 and expect

Demonstrates predictive capability of chemical kinetics in assessing clinical-stage molecules for Alzheimer’s disease (“AD”) Significant paper published in Nature Structural and Molecular Biology Co-authored by Wren’s scientific founders and senior Biogen scientists Aducanumab compared, in a blinded study, to three clinical-stage antibodies using chemical kinetics Only aducanumab dramatically reduces the flux of amyloid-β ol

ReadySet Surgical today announced the launch of RS Capture, enhancing the Company’s cloud-based, end-to-end platform to optimize hospital surgical supply chain management